ACAD FY 2013 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-76.7% YoY

Gross Profit

-$26M-2233.8% margin

Operating Income

-$38M-3344.7% margin

Net Income

-$38M-3314.2% margin

EPS (Diluted)

$-0.44

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$189M

Total Liabilities

$7M

Stockholders' Equity

$182M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$5M	-76.7%
Gross Profit	-$26M	-$14M	-84.2%
Operating Income	-$38M	-$21M	-83.4%
Net Income	-$38M	-$21M	-82.0%